Immortal time bias in observational studies of drug effects in pregnancy

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 100, Issue 9, 2014, Pages 658-662

  Matok, Ilan ^a,b   Azoulay, Laurent ^a,b   Yin, Hui ^a   Suissa, Samy ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Anti ulcer agents; Bias (epidemiology); Cohort studies; Nasal decongestants; Pregnancy; Statistics

Indexed keywords

ANTIULCER AGENT; DECONGESTIVE AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DRUG EFFECT; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM; ADOLESCENT; DIABETES MELLITUS; FACTUAL DATABASE; GESTATIONAL AGE; HYPERTENSION; MALE; NEWBORN; PRE-ECLAMPSIA; PREMATURE BIRTH; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STATISTICAL BIAS; TIME;

ADOLESCENT; ADULT; BIAS (EPIDEMIOLOGY); DATABASES, FACTUAL; DIABETES MELLITUS; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; HYPERTENSION; INFANT, NEWBORN; MALE; NASAL DECONGESTANTS; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84925956963     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23271     Document Type: Article

References (17)

1. Clark DA, Stinson EB, Griepp RB, et al. 1971. Cardiac transplantation in man. VI. Prognosis of patients selected for cardiac transplantation. Ann Intern Med 75:15-21.
2. Dattani N, Datta-Nemdharry P, Macfarlane A. 2011. Linking maternity data for England, 2005-06: methods and data quality. Health Stat Q Spring:53-79.
3. Gail MH. 1972. Does cardiac transplantation prolong life? A reassessment. Ann Intern Med 76:815-817.
4. Guyatt GH, Sackett DL, Sinclair JC, et al. 1995. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 274:1800-1804.
5. Hernandez RK, Mitchell AA, Werler MM. 2010. Decongestant use during pregnancy and its association with preterm delivery. Birth Defects Res A Clin Mol Teratol 88:715-721.
6. Johansson S, Wallander MA, de Abajo FJ, Garcia Rodriguez LA. 2010. Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. Drug Saf 33:223-232.
7. Kallen BA, Olausson PO. 2006. Use of oral decongestants during pregnancy and delivery outcome. Am J Obstet Gynecol 194:480-485.
8. Khan NF, Harrison SE, Rose PW. 2010. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 60:e128-e136.
9. Koren G, Pastuszak A, Ito S. 1998. Drugs in pregnancy. N Engl J Med 338:1128-1137.
10. Messmer BJ, Nora JJ, Leachman RD, Cooley DA. 1969. Survival-times after cardiac allografts. Lancet 1:954-956.
11. Samet JM. 2003. Measuring the effectiveness of inhaled corticosteroids for COPD is not easy! Am J Respir Crit Care Med 168:1-2.
12. Strom BL. 2005. Pharmacoepidemiology. 4th ed. Hoboken, NJ: John Wiley; xvii, 889 p.
13. Suissa S. 2003. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 168:49-53.
14. Suissa S. 2004. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 23:391-395.
15. Suissa S. 2007. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 16:241-249.
16. Suissa S. 2008. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 167:492-499.
17. Walley T, Mantgani A. 1997. The UK General Practice Research Database. Lancet 350:1097-1099.